Stocks · Health care · Pharmaceutical Preparations

Aktis Oncology, Inc.

AKTS
United States Fiscal year ends December CIK 0002035832 Results filed 13 Aug 2026

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mpm Bioventures 2018, L.p.
10% owner
—
—
—
10,260,064
$215.78M
+2,903%
Ansbert Gadicke
10% owner
—
—
—
10,260,064
$215.78M
+2,903%
Todd Foley
Director
—
—
—
4,235,403
$89.07M
—
EcoR1 Capital, LLC entity
Director
—
—
—
347,305
$7.30M
—
Vida Ventures II, LLC entity
10% owner
—
—
—
157,387
$3.31M
—
Helen Susan Kim
Director
—
—
—
157,387
$3.31M
—
Lloyd Mitchell Segal
Director
—
—
—
19,631
$412.85K
—
Ken Herrmann
Director
—
—
—
0
$0.00
—
Shulamit Ron-Bigger
Chief Operating Officer
—
—
—
0
$0.00
—
Akos Czibere
Chief Medical Officer
—
—
—
0
$0.00
—

No percentages here. This company's share count has moved by a factor of 58.4 over the window, from 915,261 to 53,446,222 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.